| Year |
Citation |
Score |
| 2022 |
Graves LV, Churchill EG, Williams ME, Van Etten EJ, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. Source recognition discriminability impairment in Huntington's versus Alzheimer's disease: Evidence from the CVLT-3. Applied Neuropsychology. Adult. 1-6. PMID 35984776 DOI: 10.1080/23279095.2022.2112682 |
0.386 |
|
| 2020 |
Corey-Bloom J, Fischer RS, Kim A, Snell C, Parkin GM, Granger DA, Granger SW, Thomas EA. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects. International Journal of Molecular Sciences. 21. PMID 32887270 DOI: 10.3390/ijms21176363 |
0.305 |
|
| 2020 |
Corey-Bloom J, Haque A, Aboufadel S, Snell C, Fischer RS, Granger SW, Granger DA, Thomas EA. Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington's Patients. Frontiers in Neuroscience. 14: 73. PMID 32194366 DOI: 10.3389/fnins.2020.00073 |
0.364 |
|
| 2020 |
Holden HM, Tierney SM, Graves LV, Beltran-Najera I, Woods SP, Snell CM, Delis DC, Corey-Bloom J, Gilbert PE. Identification of Subtle Verbal Memory Deficits in Premanifest Huntington Disease Using the California Verbal Learning Test. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 33: 16-22. PMID 32132399 DOI: 10.1097/Wnn.0000000000000219 |
0.332 |
|
| 2019 |
Gutierrez A, Corey-Bloom J, Thomas EA, Desplats P. Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients. Frontiers in Molecular Neuroscience. 12: 335. PMID 32038165 DOI: 10.3389/Fnmol.2019.00335 |
0.355 |
|
| 2019 |
Van Etten EJ, Graves LV, Taylor B, Holden HM, Lopez FV, Williams ME, Pirogovsky-Turk E, Corey-Bloom J, Filoteo VJ, Delis DC, Gilbert PE. Recall and Recognition Discriminability in Parkinson's Disease and Huntington's Disease. Journal of Huntington's Disease. PMID 31476164 DOI: 10.3233/Jhd-190346 |
0.364 |
|
| 2019 |
Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Gilbert PE, Delis DC. New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-6. PMID 31060638 DOI: 10.1017/S1355617719000407 |
0.392 |
|
| 2019 |
Graves LV, Simone S, Williams M, Courville T, Mattson SN, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3. Applied Neuropsychology. Adult. 1-8. PMID 31060389 DOI: 10.1080/23279095.2019.1605993 |
0.468 |
|
| 2019 |
Thomas E, Corey-Bloom J, Haque A, Park S. Elevated levels of salivary huntingtin protein in Huntington's disease patients Psychoneuroendocrinology. 100: S7. DOI: 10.1016/j.psyneuen.2018.12.040 |
0.325 |
|
| 2018 |
Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-9. PMID 30113280 DOI: 10.1017/S1355617718000474 |
0.345 |
|
| 2018 |
Corey-Bloom J, Haque AS, Park S, Nathan AS, Baker RW, Thomas EA. Salivary levels of total huntingtin are elevated in Huntington's disease patients. Scientific Reports. 8: 7371. PMID 29743609 DOI: 10.1038/s41598-018-25095-3 |
0.387 |
|
| 2017 |
Doyle KL, Woods SP, McDonald CR, Leyden KM, Holden HM, E Morgan E, Gilbert PE, Corey-Bloom J. Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy. Applied Neuropsychology. Adult. 1-11. PMID 28850256 DOI: 10.1080/23279095.2017.1353993 |
0.327 |
|
| 2016 |
Van Liew C, Santoro MS, Goldstein J, Gluhm S, Gilbert PE, Corey-Bloom J. Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases. American Journal of Alzheimer's Disease and Other Dementias. PMID 27678491 DOI: 10.1177/1533317516668573 |
0.42 |
|
| 2016 |
Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S. Obstructive Sleep Apnea and Cognition in Parkinson's disease. Sleep Medicine. 21: 28-34. PMID 27448468 DOI: 10.1016/J.Sleep.2016.01.001 |
0.312 |
|
| 2016 |
Graves LV, Holden HM, Delano-Wood L, Bondi MW, Woods SP, Corey-Bloom J, Salmon DP, Delis DC, Gilbert PE. Total recognition discriminability in Huntington's and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 27441951 DOI: 10.1080/13803395.2016.1204993 |
0.44 |
|
| 2016 |
Sheppard DP, Pirogovsky-Turk E, Woods SP, Holden HM, Nicoll DR, Filoteo JV, Corey-Bloom J, Gilbert PE. Everyday Functioning in Huntington's Disease: A Laboratory-Based Study of Financial Management Capacity. Applied Neuropsychology. Adult. 1-7. PMID 27077945 DOI: 10.1080/23279095.2015.1125904 |
0.344 |
|
| 2016 |
Corey-Bloom J, Gluhm S, Herndon A, Haque AS, Park S, Gilbert PE. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease. Journal of Huntington's Disease. PMID 27003664 DOI: 10.3233/JHD-150175 |
0.351 |
|
| 2015 |
Pirogovsky E, Nicoll DR, Challener DM, Breen E, Gluhm S, Corey-Bloom J, Gilbert PE. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease. Journal of Neuropsychology. 9: 77-86. PMID 24330469 DOI: 10.1111/jnp.12036 |
0.327 |
|
| 2014 |
Corey-Bloom J, Jia H, Aikin AM, Thomas EA. Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease. Journal of Huntington's Disease. 3: 311-6. PMID 25300334 DOI: 10.3233/JHD-140110 |
0.344 |
|
| 2014 |
Hall CA, Reynolds CF, Butters M, Zisook S, Simon N, Corey-Bloom J, Lebowitz BD, Begley A, Mauro C, Shear MK. Cognitive functioning in complicated grief. Journal of Psychiatric Research. 58: 20-5. PMID 25088285 DOI: 10.1016/J.Jpsychires.2014.07.002 |
0.335 |
|
| 2013 |
Medina LD, Pirogovsky E, Salomonczyk D, Goldstein J, Panzera R, Gluhm S, Simmons R, Corey-Bloom J, Gilbert PE. Postural limits of stability in premanifest and manifest Huntington's disease. Journal of Huntington's Disease. 2: 177-84. PMID 25063514 DOI: 10.3233/Jhd-130048 |
0.347 |
|
| 2013 |
Nicoll DR, Pirogovsky E, Collazo AE, Tierney SM, Corey-Bloom J, Gilbert PE. The effect of interference on temporal order memory in premanifest and manifest Huntington's disease. Journal of Huntington's Disease. 2: 297-304. PMID 25062677 DOI: 10.3233/JHD-130064 |
0.344 |
|
| 2013 |
Van Liew C, Gluhm S, Goldstein J, Cronan TA, Corey-Bloom J. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease. Psychiatry. 76: 323-35. PMID 24299091 DOI: 10.1521/psyc.2013.76.4.323 |
0.338 |
|
| 2013 |
Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1744-7. PMID 23798501 DOI: 10.1002/mds.25578 |
0.374 |
|
| 2013 |
Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 26: 1-5. PMID 23538566 DOI: 10.1097/WNN.0b013e31828b7d26 |
0.348 |
|
| 2013 |
Mickes L, Wixted JT, Peavy GM, Jacobson MW, Goldstein JL, Corey-Bloom J. Difficulty modifying a sustained motor response in prodromal Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 35: 35-40. PMID 23198997 DOI: 10.1080/13803395.2012.742039 |
0.3 |
|
| 2013 |
Sherzai A, Edland SD, Masliah E, Hansen L, Pizzo DP, Sherzai A, Corey-Bloom J. Spongiform change in dementia with Lewy bodies and Alzheimer disease. Alzheimer Disease and Associated Disorders. 27: 157-61. PMID 22546782 DOI: 10.1097/Wad.0B013E318256D507 |
0.443 |
|
| 2012 |
Lessig S, Nie D, Xu R, Corey-Bloom J. Changes on brief cognitive instruments over time in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1125-8. PMID 22692724 DOI: 10.1002/Mds.25070 |
0.394 |
|
| 2012 |
Pillai JA, Hansen LA, Masliah E, Goldstein JL, Edland SD, Corey-Bloom J. Clinical severity of Huntington's disease does not always correlate with neuropathologic stage. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1099-103. PMID 22674458 DOI: 10.1002/Mds.25026 |
0.411 |
|
| 2012 |
Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 59: 2452-63. PMID 21945695 DOI: 10.1016/J.Neuroimage.2011.08.105 |
0.387 |
|
| 2012 |
Corey-Bloom J. Treatment trials in aging and mild cognitive impairment. Current Topics in Behavioral Neurosciences. 10: 347-56. PMID 21786037 DOI: 10.1007/7854_2011_153 |
0.382 |
|
| 2012 |
Brown D, Goldstein J, Gluhm S, Gilbert P, Corey-Bloom J. Correlation between Burden of Pathology Scores and Cognitive and Functional Symptoms in Huntington's Disease (P06.038) Neurology. 78: P06.038-P06.038. DOI: 10.1212/wnl.78.1_meetingabstracts.p06.038 |
0.381 |
|
| 2012 |
Gluhm S, Goldstein J, Majid A, Corey-Bloom J. Correlations between Burden of Pathology Score and Cognitive, Motor, and Psychiatric Measures in Premanifest Huntington's Disease (preHD) (P06.036) Neurology. 78: P06.036-P06.036. DOI: 10.1212/wnl.78.1_meetingabstracts.p06.036 |
0.394 |
|
| 2012 |
Majid DSA, Stoffers D, Dale A, Goldstein J, Aron A, Corey-Bloom J. Is the Penney Burden of Pathology (BOP) Score a Reasonable Index of Disease Severity in Premanifest HD (preHD)? (P06.035) Neurology. 78: P06.035-P06.035. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.035 |
0.323 |
|
| 2011 |
Majid DS, Stoffers D, Sheldon S, Hamza S, Thompson WK, Goldstein J, Corey-Bloom J, Aron AR. Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1481-8. PMID 21484871 DOI: 10.1002/Mds.23656 |
0.364 |
|
| 2011 |
Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE. Postural deficits in Huntington's disease when performing motor skills involved in daily living. Gait & Posture. 33: 457-61. PMID 21256027 DOI: 10.1016/j.gaitpost.2010.12.025 |
0.346 |
|
| 2011 |
Rizk-Jackson A, Stoffers D, Sheldon S, Kuperman J, Dale A, Goldstein J, Corey-Bloom J, Poldrack RA, Aron AR. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques. Neuroimage. 56: 788-96. PMID 20451620 DOI: 10.1016/J.Neuroimage.2010.04.273 |
0.374 |
|
| 2010 |
Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1163-9. PMID 20629124 DOI: 10.1002/Mds.22953 |
0.437 |
|
| 2010 |
Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology. 74: 1208-16. PMID 20385893 DOI: 10.1212/Wnl.0B013E3181D8C20A |
0.338 |
|
| 2010 |
Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Archives of Neurology. 67: 154-60. PMID 20142523 DOI: 10.1001/Archneurol.2009.334 |
0.381 |
|
| 2010 |
Lessig S, Goldstein J, Corey-Bloom J. Poster 5: Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease Neurotherapeutics. 7: 139-139. DOI: 10.1016/J.Nurt.2009.09.006 |
0.389 |
|
| 2010 |
Moser K, Biglan KM, Ross CA, Langbehn DR, Aylward E, Stout JC, Queller S, Carlozzi N, Duff K, Beglinger LJ, Paulsen JS, Tomusk A, Lifer S, Hastings S, Dawson J, ... ... Corey-Bloom J, et al. Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group Neurotherapeutics. 5: 202-212. DOI: 10.1016/J.Nurt.2007.10.053 |
0.302 |
|
| 2009 |
Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 5: 305-9. PMID 19968005 DOI: 10.5664/Jcsm.27538 |
0.387 |
|
| 2009 |
Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Medicine. 10: 1101-6. PMID 19699148 DOI: 10.1016/J.Sleep.2008.12.016 |
0.313 |
|
| 2009 |
Pirogovsky E, Goldstein J, Peavy G, Jacobson MW, Corey-Bloom J, Gilbert PE. Temporal order memory deficits prior to clinical diagnosis in Huntington's disease. Journal of the International Neuropsychological Society : Jins. 15: 662-70. PMID 19635179 DOI: 10.1017/S1355617709990427 |
0.319 |
|
| 2009 |
Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. Journal of the International Neuropsychological Society : Jins. 15: 890-7. PMID 19570306 DOI: 10.1017/S1355617709090638 |
0.337 |
|
| 2009 |
Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. Quantification of five neuropsychological approaches to defining mild cognitive impairment. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 368-75. PMID 19390294 DOI: 10.1097/Jgp.0B013E31819431D5 |
0.372 |
|
| 2009 |
Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 166-9. PMID 19155748 DOI: 10.1097/Jgp.0B013E318187De18 |
0.335 |
|
| 2009 |
Stoffers D, Kuperman J, Sheldon S, Hagler D, Goldstein J, Poldrack R, Dale A, Corey-Bloom J, Aron A. Structural imaging in presymptomatic Huntington's disease confirms that the degree of atrophy of striatum and pallidum strongly predicts years to clinical onset Neuroimage. 47: S114. DOI: 10.1016/S1053-8119(09)71052-3 |
0.329 |
|
| 2008 |
Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. Journal of the American Geriatrics Society. 56: 2076-81. PMID 18795985 DOI: 10.1111/J.1532-5415.2008.01934.X |
0.433 |
|
| 2008 |
Marcotte TD, Rosenthal TJ, Roberts E, Lampinen S, Scott JC, Allen RW, Corey-Bloom J. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Archives of Physical Medicine and Rehabilitation. 89: 1753-8. PMID 18760160 DOI: 10.1016/j.apmr.2007.12.049 |
0.302 |
|
| 2008 |
Fine EM, Delis DC, Wetter SR, Jacobson MW, Hamilton JM, Peavy G, Goldstein J, McDonald C, Corey-Bloom J, Bondi MW, Salmon DP. Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II. Journal of Clinical and Experimental Neuropsychology. 30: 463-70. PMID 18415887 DOI: 10.1080/13803390701531912 |
0.458 |
|
| 2008 |
Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs & Aging. 25: 163-74. PMID 18257603 DOI: 10.2165/00002512-200825020-00008 |
0.311 |
|
| 2007 |
Pirogovsky E, Gilbert PE, Jacobson M, Peavy G, Wetter S, Goldstein J, Corey-Bloom J, Murphy C. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 29: 395-404. PMID 17497563 DOI: 10.1080/13803390600726829 |
0.305 |
|
| 2007 |
Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW. Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dementia and Geriatric Cognitive Disorders. 23: 382-9. PMID 17389798 DOI: 10.1159/000101340 |
0.342 |
|
| 2007 |
Yaari R, Corey-Bloom J. Alzheimer's disease. Seminars in Neurology. 27: 32-41. PMID 17226739 DOI: 10.1055/s-2006-956753 |
0.319 |
|
| 2007 |
Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging. 28: 238-47. PMID 16434125 DOI: 10.1016/J.Neurobiolaging.2005.12.013 |
0.499 |
|
| 2006 |
Cooke JR, Liu L, Natarajan L, He F, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Greenfield D, Ancoli-Israel S. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behavioral Sleep Medicine. 4: 219-27. PMID 17083302 DOI: 10.1207/S15402010Bsm0404_2 |
0.332 |
|
| 2006 |
Cooke JR, Loredo JS, Liu L, Marler M, Corey-Bloom J, Fiorentino L, Harrison T, Ancoli-Israel S. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs & Aging. 23: 503-11. PMID 16872233 DOI: 10.2165/00002512-200623060-00005 |
0.327 |
|
| 2006 |
Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Liu L, Ancoli-Israel S. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing. Journal of the American Geriatrics Society. 54: 777-81. PMID 16696743 DOI: 10.1111/J.1532-5415.2006.00694.X |
0.3 |
|
| 2006 |
Ayalon L, Ancoli-Israel S, Stepnowsky C, Marler M, Palmer BW, Liu L, Loredo JS, Corey-Bloom J, Greenfield D, Cooke J. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 176-80. PMID 16473983 DOI: 10.1097/01.Jgp.0000192484.12684.Cd |
0.362 |
|
| 2006 |
Tiraboschi P, Salmon DP, Hansen LA, Hofstetter RC, Thal LJ, Corey-Bloom J. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain : a Journal of Neurology. 129: 729-35. PMID 16401618 DOI: 10.1093/Brain/Awh725 |
0.619 |
|
| 2005 |
Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. The relationship between dementia severity and rest/activity circadian rhythms. Neuropsychiatric Disease and Treatment. 1: 155-63. PMID 18568061 DOI: 10.2147/Nedt.1.2.155.61043 |
0.382 |
|
| 2005 |
Delis DC, Wetter SR, Jacobson MW, Peavy G, Hamilton J, Gongvatana A, Kramer JH, Bondi MW, Corey-Bloom J, Salmon DP. Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. Journal of the International Neuropsychological Society : Jins. 11: 708-15. PMID 16248906 DOI: 10.1017/S1355617705050812 |
0.389 |
|
| 2005 |
Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 20: 120-32. PMID 15990426 DOI: 10.1159/000086613 |
0.439 |
|
| 2005 |
Lineweaver TT, Salmon DP, Bondi MW, Corey-Bloom J. Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotation. Journal of the International Neuropsychological Society : Jins. 11: 30-9. PMID 15686606 DOI: 10.1017/S1355617705050034 |
0.435 |
|
| 2004 |
Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. The timing of activity rhythms in patients with dementia is related to survival. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 59: 1050-5. PMID 15528777 DOI: 10.1093/Gerona/59.10.M1050 |
0.342 |
|
| 2004 |
Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology. 62: 1984-9. PMID 15184601 DOI: 10.1212/01.Wnl.0000129697.01779.0A |
0.6 |
|
| 2004 |
Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 62: 1977-83. PMID 15184600 DOI: 10.1212/01.Wnl.0000128091.92139.0F |
0.573 |
|
| 2004 |
Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Alzheimer disease without neocortical neurofibrillary tangles: "a second look". Neurology. 62: 1141-7. PMID 15079014 DOI: 10.1212/01.Wnl.0000118212.41542.E7 |
0.634 |
|
| 2004 |
Hamilton JM, Wolfson T, Peavy GM, Jacobson MW, Corey-Bloom J. Rate and correlates of weight change in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 209-12. PMID 14742590 DOI: 10.1136/Jnnp.2003.017822 |
0.346 |
|
| 2004 |
Corey-Bloom J, Yan B, Gold M, Truyen L. O1-05-01 The safety and efficacy of an extended-release formulation of galantamine (reminyl ER) in the treatment of Alzheimer's disease Neurobiology of Aging. 25: S18-S19. DOI: 10.1016/S0197-4580(04)80060-5 |
0.303 |
|
| 2003 |
Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. Journal of the International Neuropsychological Society : Jins. 9: 783-95. PMID 12901784 DOI: 10.1017/S1355617703950119 |
0.693 |
|
| 2003 |
Gehrman PR, Martin JL, Shochat T, Nolan S, Corey-Bloom J, Ancoli-Israel S. Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 426-33. PMID 12837671 DOI: 10.1097/00019442-200307000-00005 |
0.39 |
|
| 2003 |
Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 60: 1586-90. PMID 12771246 DOI: 10.1212/01.Wnl.0000065889.42856.F2 |
0.646 |
|
| 2003 |
Corey-Bloom J. Galantamine: a review of its use in Alzheimer's disease and vascular dementia. International Journal of Clinical Practice. 57: 219-23. PMID 12723727 |
0.338 |
|
| 2003 |
Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 194-203. PMID 12611749 DOI: 10.1097/00019442-200303000-00010 |
0.365 |
|
| 2003 |
Hamilton JM, Salmon DP, Corey-Bloom J, Gamst A, Paulsen JS, Jerkins S, Jacobson MW, Peavy G. Behavioural abnormalities contribute to functional decline in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 120-2. PMID 12486282 DOI: 10.1136/Jnnp.74.1.120 |
0.382 |
|
| 2003 |
Smith R, Roher A, Appel S, Doody R, Killian J, Corey-Bloom J, Sabbagh M. Autonomic Sudomotor Dysfunction in Alzheimers Disease Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 3: 77-84. DOI: 10.2174/1568013033358617 |
0.431 |
|
| 2002 |
Corey-Bloom J. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias. International Psychogeriatrics / Ipa. 14: 51-75. PMID 12636180 DOI: 10.1017/S1041610203008664 |
0.488 |
|
| 2002 |
Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry. 59: 946-51. PMID 12365882 DOI: 10.1001/Archpsyc.59.10.946 |
0.624 |
|
| 2000 |
Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology. 55: 1278-83. PMID 11087768 DOI: 10.1212/Wnl.55.9.1278 |
0.62 |
|
| 2000 |
Rei RT, Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thal LJ. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease. Neurobiology of Aging. 21: 741-6. PMID 11016544 DOI: 10.1016/S0197-4580(00)00168-8 |
0.519 |
|
| 2000 |
Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies. Archives of Neurology. 57: 347-51. PMID 10714660 DOI: 10.1001/Archneur.57.3.347 |
0.612 |
|
| 2000 |
Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom J. Cholinergic dysfunction in diseases with Lewy bodies. Neurology. 54: 407-11. PMID 10668703 DOI: 10.1212/Wnl.54.2.407 |
0.599 |
|
| 2000 |
Corey-Bloom J, Tiraboschi P, Hansen LA, Alford M, Schoos B, Sabbagh MN, Masliah E, Thal LJ. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease. Neurology. 54: 403-6. PMID 10668702 DOI: 10.1212/Wnl.54.2.403 |
0.57 |
|
| 1999 |
Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thomas R, Masliah E, Thal LJ. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease. Archives of Neurology. 56: 1458-61. PMID 10593300 DOI: 10.1001/Archneur.56.12.1458 |
0.598 |
|
| 1998 |
Sabbagh MN, Reid RT, Corey-Bloom J, Rao TS, Hansen LA, Alford M, Masliah E, Adem A, Lloyd GK, Thal LJ. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 709-17. PMID 9826113 DOI: 10.1007/S007020050090 |
0.508 |
|
| 1998 |
Grundman M, Corey-Bloom J, Thal LJ. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. Journal of Neural Transmission. Supplementum. 53: 255-75. PMID 9700663 |
0.492 |
|
| 1997 |
Symonds LL, Olichney JM, Jernigan TL, Corey-Bloom J, Healy JF, Jeste DV. Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 251-8. PMID 9144105 DOI: 10.1176/Jnp.9.2.251 |
0.308 |
|
| 1997 |
Corey-Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, Thal LJ. Hippocampal sclerosis contributes to dementia in the elderly. Neurology. 48: 154-60. PMID 9008511 DOI: 10.1212/Wnl.48.1.154 |
0.617 |
|
| 1996 |
Cahn DA, Salmon DP, Monsch AU, Butters N, Wiederholt WC, Corey-Bloom J, Barrett-Connor E. Screening for dementia of the alzheimer type in the community: the utility of the Clock Drawing Test. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 11: 529-39. PMID 14588458 DOI: 10.1016/0887-6177(95)00041-0 |
0.434 |
|
| 1996 |
Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. Journal of the American Geriatrics Society. 44: 1147-52. PMID 8855991 |
0.313 |
|
| 1996 |
Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 46: 1585-91. PMID 8649553 DOI: 10.1212/Wnl.46.6.1585 |
0.561 |
|
| 1995 |
Cahn DA, Salmon DP, Butters N, Wiederholt WC, Corey-Bloom J, Edelstein SL, Barrett-Connor E. Detection of dementia of the Alzheimer type in a population-based sample: neuropsychological test performance. Journal of the International Neuropsychological Society : Jins. 1: 252-60. PMID 9375219 DOI: 10.1017/S1355617700000242 |
0.44 |
|
| 1995 |
Olichney JM, Galasko D, Corey-Bloom J, Thal LJ. The spectrum of diseases with diffuse Lewy bodies. Advances in Neurology. 65: 159-70. PMID 7872137 |
0.411 |
|
| 1995 |
Corey-Bloom J, Thal LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ. Diagnosis and evaluation of dementia. Neurology. 45: 211-8. PMID 7854514 DOI: 10.1212/Wnl.45.2.211 |
0.598 |
|
| 1995 |
Corey-Bloom J, Galasko D. Adjunctive therapy in patients with Alzheimer's disease. A practical approach. Drugs & Aging. 7: 79-87. PMID 7579786 DOI: 10.2165/00002512-199507020-00002 |
0.568 |
|
| 1993 |
Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. Journal of the American Geriatrics Society. 41: 31-7. PMID 8418119 DOI: 10.1111/J.1532-5415.1993.Tb05944.X |
0.68 |
|
| 1993 |
Galasko D, Abramson I, Corey-Bloom J, Thal LJ. Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer's disease. Neurology. 43: 1559-63. PMID 8351011 DOI: 10.1212/Wnl.43.8.1559 |
0.629 |
|
| 1992 |
Galasko D, Corey-Bloom J, Thal LJ. In reply Journal of the American Geriatrics Society. 40: 538. DOI: 10.1111/j.1532-5415.1992.tb02031.x |
0.328 |
|
| 1991 |
Galasko D, Corey-Bloom J, Thal LJ. Monitoring progression in Alzheimer's disease. Journal of the American Geriatrics Society. 39: 932-41. PMID 1842209 DOI: 10.1111/J.1532-5415.1991.Tb04463.X |
0.641 |
|
| Show low-probability matches. |